New Predictors May Determine Metabolic Risk in Kids on Atypicals

pharma doctor

Large waist circumference and a specific variation may be accurate predictors of an increased risk for metabolic syndrome in children prescribed second-generation antipsychotics.
Medscape Medical News

Read more…

Link Between Parabens and Breast Cancer?

pharma doctors

A new study has found traces of parabens in breast tumors. Do they play a role in the development of ?
Medscape Medical News

Read more…

Once-Weekly Diabetes Treatment Gets FDA OK

doctor

WASHINGTON (MedPage Today) — The delay is over for the diabetes Bydureon (exenatide extended-release), with FDA approval making it the first once-weekly treatment for type 2 disease.

Read more…

OIG: Feds Don’t Know Who’s Opted Out of Medicare

pharma doctor

WASHINGTON (MedPage Today) — Medicare doesn’t adequately track which physicians are opting out of Medicare, making it nearly impossible to determine who is cutting ties with the program and why, according to an OIG memo.

Read more…

Traffic-Related Asthma Costs Underestimated (CME/CE)

pharma doctors

(MedPage Today) — The impact that motor vehicle exhaust has on asthma costs is much bigger than once thought, researchers warned.

Read more…

FDA Supplement Guidance Not Strict Enough, MD Says

pharma doctors

(MedPage Today) — An FDA proposal to require dietary supplement manufacturers to submit data proving their product is safe doesn’t go far enough, one expert charged.

Read more…

Bird Flu Research Debate Leaves Docs Up in the Air

pharma doctors

(MedPage Today) — What should be done about controversial research on the H5N1 avian flu that some think should be suppressed and others think has important benefits that should be pursued?

Read more…

Cancer Screening Falls Short, CDC Says (CME/CE)

doctors

(MedPage Today) — Large numbers of Americans who should have screening exams for breast, colon, and cervical are not getting them, government researchers said.

Read more…

Once-Weekly Diabetes Treatment Gets FDA OK

doc

WASHINGTON (MedPage Today) — The delay is over for the diabetes Bydureon (exenatide extended-release), with FDA approval making it the first once-weekly treatment for type 2 disease.

Read more…

FDA OKs Axitinib for Kidney Cancer

doctors

(MedPage Today) — Another angiogenesis blocker, axitinib (Inlyta), has won FDA approval as a second-line treatment for advanced kidney , the agency said Friday.

Read more…